KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) FCF Payout Ratio (2019 - 2025)

Historic FCF Payout Ratio for Royalty Pharma (RPRX) over the last 7 years, with Q3 2025 value amounting to 0.13.

  • Royalty Pharma's FCF Payout Ratio fell 10929.12% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17, marking a year-over-year increase of 13008.91%. This contributed to the annual value of 0.48 for FY2024, which is 24689.69% up from last year.
  • Per Royalty Pharma's latest filing, its FCF Payout Ratio stood at 0.13 for Q3 2025, which was down 10929.12% from 0.11 recorded in Q2 2025.
  • Over the past 5 years, Royalty Pharma's FCF Payout Ratio peaked at 5.46 during Q1 2021, and registered a low of 0.72 during Q4 2021.
  • Moreover, its 5-year median value for FCF Payout Ratio was 0.08 (2022), whereas its average is 0.27.
  • Per our database at Business Quant, Royalty Pharma's FCF Payout Ratio surged by 115768.27% in 2021 and then tumbled by 88120.14% in 2024.
  • Over the past 5 years, Royalty Pharma's FCF Payout Ratio (Quarter) stood at 0.72 in 2021, then surged by 114.34% to 0.1 in 2022, then plummeted by 202.85% to 0.11 in 2023, then surged by 219.81% to 0.13 in 2024, then crashed by 203.48% to 0.13 in 2025.
  • Its FCF Payout Ratio was 0.13 in Q3 2025, compared to 0.11 in Q2 2025 and 0.09 in Q1 2025.